The page lists 58 projects related to the topic "amyloid".
| # | |||
|---|---|---|---|
| 1 | BacBio | Mechanistic and functional studies of Bacillus biofilms assembly on plants, and their impact in sustainable agriculture and food safety | 2015 |
| 2 | aLzINK | Alzheimer's disease and Zinc: the missing link ? | 2015 |
| 3 | Weakinteract | Weak interactions in self-organizations studied by NMR spectroscopy in the supramolecular solid-state | 2015 |
| 4 | BAS-SBBT | Bacterial Amyloid Secretion: Structural Biology and Biotechnology. | 2015 |
| 5 | CAREMiBRAIN | A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline | 2014 |
| 6 | OPTIMAL NMR | Optimal control methods for biological solid state nuclear magnetic resonance | 2015 |
| 7 | MetAccembly | Accelerating metal-directed assembly, recognition and catalysis with computational methods | 2015 |
| 8 | NeuroInCellNMR | In-cell NMR monitoring of alpha-Synuclein aggregation in neuronal cells | 2015 |
| 9 | MANGO | The determinants of cross-seeding of protein aggregation: a Multiple TANGO | 2015 |
| 10 | Dementia | DNA rEpair impaired Mice with accElerated Neurodegeneration as Tool to Improve Alzheimer therapeutics | 2015 |
| 11 | OPTIMALZ | Optical imaging of ocular pathology in Alzheimer’s disease | 2015 |
| 12 | BeadDiagnosis | Prognosis and Diagnosis of Protein Misfolding Diseases by Seeded Aggregation in Microspheres | 2015 |
| 13 | MAIN | Molecular Adhesion and Interactions in the Nervous system | 2016 |
| 14 | microCrysFact | Microfluidic Crystal Factories (μ-CrysFact): a breakthrough approach for crystal engineering | 2016 |
| 15 | NEUROTUNN | Mechanisms of α-synuclein spreading, implications for synucleinopathies | 2016 |
| 16 | CONNECT | Connecting neuronal network activity with regional specificity for Alzheimer pathology: a multi-modal neuroimaging approach | 2018 |
| 17 | VIBRANT-BIO | High-throughput vibrational fingerprinting by nanoplasmonics for disease biology | 2017 |
| 18 | NPAD | Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease | 2016 |
| 19 | AD-gut | Alzheimer Disease - gut connection | 2016 |
| 20 | Neurotoxic | An Ultra-sensitive Assay to Measure Oligomer Induced Toxicity in Human Cerebrospinal Fluid | 2016 |
| 21 | IMMUNOALZHEIMER | The role of immune cells in Alzheimer's disease | 2016 |
| 22 | CAREMIBRAIN | A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline | 2016 |
| 23 | AD-VIP | Alzheimer’s disease and AAV9: Use of a virus-based delivery system for vectored immunoprophylaxis in dementia. | 2016 |
| 24 | SYNDEGEN | Synaptic dysfunction in Neurodegenerative Diseases | 2017 |
| 25 | ALZSYN | Imaging synaptic contributors to dementia | 2016 |
| 26 | PATHAD | Pathways to Alzheimer's disease | 2016 |
| 27 | toxiclipasyn | Understanding the balance between functional and deleterious interactions of alpha-synuclein with lipid bilayers | 2017 |
| 28 | AlzDiabetes | Insulin resistance and Tauopathy : Insights from Drosophila models and human brain samples | 2016 |
| 29 | eWAD | Unbalanced Wnt signalling in AD: a DNA methylation effect | 2017 |
| 30 | meltRBP | Tracking interactions between RNA and RNA-binding proteins by thermal profiling of the proteome | 2017 |
| 31 | FreezeAlz | Theoretical prediction of spectral biomarkers for Alzheimer's disease enabled by highly efficient and adaptable mutli-level response methods | 2017 |
| 32 | AMYPAD | Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 | 2016 |
| 33 | PHAGO | Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 | 2016 |
| 34 | MOPEAD | Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 | 2016 |
| 35 | TryptoBoost | Boosting tryptophan fluorescence with optical nanoantennas to watch label-free protein dynamics with single molecule resolution at high concentration | 2017 |
| 36 | FASTER | Faster magic-angle spinning leads to a resolution revolution in biological solid-state NMR | 2017 |
| 37 | BETACONTROL | Control of amyloid formation via beta-hairpin molecular recognition features | 2017 |
| 38 | BrainDrain | Translational implications of the discovery of brain-draining lymphatics | 2017 |
| 39 | GlymphEye | The Ocular Glymphatic System | 2017 |
| 40 | DORMANTOOCYTE | Understanding the Balbiani body: A super-organelle linked to dormancy in oocytes | 2018 |
| 41 | UPRECON | Ultrafast photonics for the detection and recognition of toxic spine-structures of amyloid aggregates linked to neurodegenerative disease | 2018 |
| 42 | BOLD-NMR | Biomolecular structures elucidated by cOLD magic angle spinning NMR with dynamic nuclear polarization | 2018 |
| 43 | AMNEsIA | Interactions of amyloid peptides with the neuronal membrane interface: molecular mechanisms involved in Alzheimer’s disease | 2018 |
| 44 | Human Glymphatics | Effects of sleep deprivation and adrenergic inhibition on glymphatic flow in humans | 2018 |
| 45 | NMR-DisAgg | The Dynamic Composition of the Protein Chaperone Network: Unraveling Human Protein Disaggregation via NMR Spectroscopy | 2018 |
| 46 | BrainNanoFlow | Nanoscale dynamics in the extracellular space of the brain in vivo | 2018 |
| 47 | VITAE | VIrTual BrAin PErfusion: Assessing cerebrovascular function by High Performance Computing from 3D brain vessel network data for vascular-targeted drug development in neurodegenerative diseases. | 2018 |
| 48 | PHOTOMASS | Imaging Biomolecular Self-Assembly with a Molecular Photonic Scale | 2019 |
| 49 | MicroSPARK | A Single-Molecule Technology for Resolving Chaperone Action in Neurodegenerative Diseases | 2019 |
| 50 | BRIGHT | 40 Hz Masked Light: A new venture to slow the progression of Alzheimer’s Disease | 2019 |
| 51 | VERDAD | A blood based biomarker identifying early Alzheimer Disease's pathology | 2019 |
| 52 | AmInnovation | Disruptive Innovation to Treat Alzheimer’s and Parkinson’s diseases: new target, new patented drug, new therapeutic strategy. | 2019 |
| 53 | variaTECT | A novel genetic assay for risk assessment of cognitive decline in Alzheimer’s Disease | 2019 |
| 54 | ADAMtx | ADAMtx: Development of Alzheimer’s immunotherapy by harnessing the natural reparative properties of microglia | 2019 |
| 55 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 56 | PreSynPlast | Molecular mechanisms of presynaptic plasticity | 2020 |
| 57 | TS4NC | TS4NC: Therapeutic S4N Chelation targeting Alzheimer's Disease. | 2020 |
| 58 | AlzheimersInAction | AlzheimersInAction: A multi-disciplinary approach to determine the cellular and molecular mechanisms underlying the inflammatory response to amyloid-β in Alzheimer’s disease. | 2021 |